Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer

E-ISSN： 1873-5576|9|2|148-162

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.9, Iss.2, 2009-03, pp. : 148-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Targeted Therapies to Overcome Trastuzumab Resistance in HER2- Overexpressing Metastatic Breast Cancer

Current Drug Targets, Vol. 14, Iss. 8, 2013-07 ,pp. : 889-898

Bentham Science Publishers

Access to resources Recommend Favorite

HER-2-positive metastatic breast cancer: trastuzumab and beyond

By Metro Giulio Mottolese Marcella Fabi Alessandra

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2583-2601

Informa Healthcare

Access to resources Recommend Favorite

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer

Current Cancer Drug Targets, Vol. 15, Iss. 8, 2015-01 ,pp. : 665-683

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacodiagnostic Testing in Breast Cancer: Focus on HER2 and Trastuzumab Therapy

By Bartlett John M.S.

American Journal of PharmacoGenomics, Vol. 5, Iss. 5, 2005-01 ,pp. : 303-315

Adis International

Access to resources Recommend Favorite

Overcoming Treatment Resistance in HER2-Positive Breast Cancer: Potential Strategies

By Puglisi Fabio >

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1175-1193

Adis International

Access to resources Recommend Favorite